In vitro controlled release of Rifampicin through liquid-crystalline folate nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 129, Issue , 2015, Pages 198-205

  Parmar, Rohan ^a   Misra, Rahul ^a   Mohanty, Sanat ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY DELHI   (India)

Author keywords

Alveolar macrophage; Control release; Liquid crystalline folate; Rifampicin; Tuberculosis

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; CRYSTALLINE MATERIALS; CYTOTOXICITY; DRUG THERAPY; FLUORESCENCE MICROSCOPY; LIQUIDS; MACROPHAGES; NANOPARTICLES; POSITIVE IONS;

ALVEOLAR MACROPHAGES; CONTROL RELEASE; LIQUID CRYSTALLINE; RIFAMPICIN; TUBERCULOSIS;

LOADING;

FOLATE NANOPARTICLE; FOLIC ACID; NANOPARTICLE; RIFAMPICIN; UNCLASSIFIED DRUG; CROSS LINKING REAGENT; DELAYED RELEASE FORMULATION; DRUG CARRIER; TUBERCULOSTATIC AGENT;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSS LINKING; CYTOTOXICITY; DRUG DELIVERY SYSTEM; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; ADMINISTRATION AND DOSAGE; ANIMAL; BIOAVAILABILITY; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; LIQUID CRYSTAL; MEDICINAL CHEMISTRY; MOUSE; PARTICLE SIZE;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; BIOLOGICAL AVAILABILITY; CELL SURVIVAL; CELLS, CULTURED; CHEMISTRY, PHARMACEUTICAL; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FOLIC ACID; IN VITRO TECHNIQUES; LIQUID CRYSTALS; MACROPHAGES, ALVEOLAR; MICE; NANOPARTICLES; PARTICLE SIZE; RIFAMPIN;

EID: 84930044360     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.03.051     Document Type: Article

References (23)

1. du Toit L.C., Pillay V., Danckwerts M.P. Tuberculosis chemotherapy: current drug delivery approaches. Respir. Res. 2006, 7:118-136.
2. Gelperina S., Kisich K., Iseman M.D., Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am. J. Respir. Crit. Care Med. 2005, 172:1487-1490.
3. Peters K., et al. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J. Antimicrob. Chemother. 2000, 45(1):77-83.
4. Bakker-Woudenberg I.A., et al. Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J. Infect. Dis. 1993, 168(1):164-171.
5. Clemens D.L., et al. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrob. Agents Chemother. 2012, 56(5):2535-2545.
6. Zahoor A., Sharma S., Khuller G.K. Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis. Int. J. Antimicrob. Agents 2005, 26(4):298-303.
7. Pandey R., Khuller G.K. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 2005, 85:227-234.
8. Pandey R., Zahoor A., Sharma S., Khuller G.K. Nanoparticle encapsulated anti tubercular drugs as a potential oral drug delivery system against murine tuberculosis. Tuberculosis 2003, 83:373-378.
9. Deol P., Khuller G.K. Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal anti-tubercular drugs. Biochim. Biophys. Acta 1997, 41:1211-1214.
10. Motkar G., Lonare M., Patil O., Mohanty S. Self-assembly of folic acid in aqueous media. AIChE J. 2013, 59:1360-1368.
11. Shuaibi A.M., Sevenhuysen G.P., House J.D. The importance of using folate intake expressed as dietary folate equivalents in predicting folate status. J. Food Compos. Anal. 2009, 22(1):38-43.
12. Misra R., Lonare M., Gupta R., Mohanty S. Engineering chromonic nanoparticles from liquid-crystalline folate solutions. Sci. Adv. Mater. 2014, 6:1-9.
13. de Silva D.J., Olver J.M. Hydroxypropyl methylcellulose (HPMC) lubricant facilitates insertion of porous spherical orbital implants. Ophthalmic Plast. Reconstr. Surg. 2005, 21(4):301-302.
14. Ciuchi F., Di Nicola G., Franz H., Gottarelli G., Mariani P., Ponzi Bossi M.G., Spada G.P. Self recognition and self-assembly of folic acid salts: columnar liquid crystalline polymorphism and the column growth process. J. Am. Chem. Soc. 1994, 116:7064-7071.
15. Swami A., Shi J., Gadde S., Votruba A.R., Kolishetti N., Farokhzad O.C. Nanoparticles for Targeted and Temporally Controlled Drug Delivery. Nanostructure Science and Technology: Multifunctional Nanoparticles for Drug Delivery Applications 2012, 9-29.
16. Fotakis G., Timbrell J.A. In vitro cytotoxicity assays: comparison of LDH, neutral red. MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 2006, 160:171-177.
17. Mundy K., Sleep J.C., Lydon J.E. The intercalation of ethidium bromide in the chromonic lyotropic phases of drugs and nucleic acids. Liq. Cryst. 1995, 19:107-112.
18. Mu L., Feng S.S. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J. Control. Release 2003, 86(1):33-48.
19. Govender T., Stolnik S., Garnett M.C., Illum L., Davis S.S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J. Control. Release 1999, 57(2):171-185.
20. Ahmadi M., Fattahi A. On the binding of Mg2+, Ca2+, Zn2+ and Cu2+ metal cations to 20-deoxyguanosine: changes on sugar puckering and strength of the N-glycosidic bond. Sci. Iran. 2011, 18:1343-1352.
21. Chuan J., Li Y., Yang L., Sun X., Zhang Q., Gong T., Zhang Z. Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles. J. Nanopart. Res. 2013, 15:1634.
22. Des Jardin L.E., Kaufman T.M., Potts B., Kutzbach B., Yi H., Schlesinger L.S. Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FccRII and the mannose receptor. Microbiology 2002, 148:3161-3171.
23. Jiang P., Gua Z. Fluorescent detection of zinc in biological systems: recent development on the design of chemosensors and biosensors. Coord. Chem. Rev. 2004, 248:205-229.